North America
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
GSK and CureVac will together receive $740 million, as well as royalties on sales of COVID-19 vaccines in the US
News of a trade secrets leak involving TSMC and an action in Japan against AI startup Perplexity were also among the top talking points
Sponsored
Sponsored
-
Sponsored by CASPatent rejections are common, but avoidable, setbacks. This CAS article explores how comprehensive intellectual property insights, expert searches, and proactive strategies can help innovators anticipate rejections and secure stronger patent applications -
Sponsored by CASKathy Van der Herten and Don Swartwout of CAS discuss the benefits and challenges of using emerging technologies to help with IP searches
-
Sponsored by Ropes & GrayLawyers from Ropes & Gray joined Managing IP to discuss licensing negotiation groups
-
Sponsored by CASPatent landscape analysis helps R&D teams identify trends, optimise resources, and seize innovation opportunities. This article, originally published by CAS, explains how to leverage the right tools to stay ahead of the competition
-
Sponsored by CASMatt Garver and Peter Mattei of CAS explain what information companies should be getting from patent monitoring programmes
-
Sponsored by CASMatt Garver and Peter Mattei of CAS discuss why companies should develop patent monitoring programmes
North American Jurisdictions